한글목차

세계의 디지털 맘모그래피 시장 규모는 2024년에 11억 2,000만 달러에 달하며, 예측 기간에는 2030년까지 CAGR 9.39%로 견고한 성장이 예측됩니다.

세계의 디지털 맘모그래피 시장은 최근 수년간 큰 성장과 변화를 겪으며 유방암 진단의 전망에 혁명을 일으켰습니다. 최첨단 영상 기술인 디지털 유방촬영술은 기존의 필름 기반 유방촬영술을 대체하여 우수한 이미지 품질, 향상된 진단 정확도, 간소화된 워크플로우를 제공합니다. 디지털 맘모그래피 시장 확대는 전 세계 유방암 발병률 증가, 유방암에 대한 인식 개선, 조기 발견을 위한 노력 등이 주요 요인으로 작용하고 있습니다. 디지털 맘모그래피는 종양과 석회화를 포함한 유방의 이상 징후를 보다 높은 민감도와 특이성으로 쉽게 감지할 수 있게 해 결과 개선과 사망률 감소로 이어질 수 있습니다.

디지털 맘모그래피의 기술적 진보가 시장의 진화에 중요한 역할을 담당했습니다. 풀필드 디지털 유방촬영술(FFDM)과 디지털 유방 투시촬영(DBT)과 같은 기술 혁신이 각광을 받으면서 유방 조직을 보다 종합적이고 상세하게 볼 수 있는 3차원 영상 처리 기능을 제공하게 되었습니다. 이는 기존 2차원 유방촬영술의 한계를 극복하는 데 도움이 되며, 특히 유선 조직이 밀집된 경우 유용하다는 것이 입증되었습니다. 인공지능(AI)과 머신러닝 알고리즘의 통합은 방사선과 전문의가 유방 촬영 영상을 해석하는 데 도움을 주어 진단 정확도를 더욱 높이고, 위양성을 줄이며, 효율성을 높이고 있습니다.

주요 시장 성장 촉진요인

유방암의 유병률 증가

주요 시장이 해결해야 할 과제

높은 초기 비용과 경제적 제약

주요 시장 동향

3D 맘모그래피(디지털 유방촬영술)의 부상

목차

제1장 제품 개요

제2장 조사 방법

제3장 개요

제4장 세계의 디지털 맘모그래피 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 제품별(2D 풀필드 디지털 맘모그래피 토모신테시스, 3D 풀필드 디지털 맘모그래피 토모신테시스)
  • 최종사용자별(병원, 외래 수술 센터, 기타 최종사용자)
  • 지역별
  • 기업별(2024년)
• 시장 맵
  • 제품별
  • 최종사용자별
  • 지역별

제5장 아시아태평양의 디지털 맘모그래피 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 제품별
  • 최종사용자별
  • 국가별
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 호주
  • 일본
  • 한국

제6장 유럽의 디지털 맘모그래피 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 스페인
  • 이탈리아
  • 영국

제7장 북미의 디지털 맘모그래피 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제8장 남미의 디지털 맘모그래피 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제9장 중동 및 아프리카의 디지털 맘모그래피 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 이집트

제10장 시장 역학

• 촉진요인
• 과제

제11장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 합병과 인수

제12장 세계의 디지털 맘모그래피 시장 : SWOT 분석

제13장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Hologic Inc .
• GE Healthcare
• Koninklijke Philips NV
• Siemens Healthcare GmBH
• Fujifilm Corporation
• Planmed Oy
• Toshiba Medical Systems
• Metaltronica S.p.A

제15장 전략적 제안

제16장 조사회사 소개·면책사항

영문목차

Global Digital Mammography Market was valued at USD 1.12 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 9.39% through 2030. The Global Digital Mammography Market has experienced significant growth and transformation in recent years, revolutionizing the landscape of breast cancer diagnostics. Digital mammography, a state-of-the-art imaging technology, has replaced traditional film-based mammography, offering superior image quality, enhanced diagnostic accuracy, and streamlined workflow. The market's expansion is primarily driven by the rising prevalence of breast cancer worldwide, coupled with increasing awareness and early detection initiatives. Digital mammography facilitates the detection of breast abnormalities, including tumors and calcifications, with greater sensitivity and specificity, leading to improved outcomes and reduced mortality rates.

Technological advancements in digital mammography have played a pivotal role in market evolution. Innovations such as full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) have gained prominence, providing three-dimensional imaging capabilities that offer a more comprehensive and detailed view of breast tissue. This has proven particularly beneficial in overcoming the limitations of conventional two-dimensional mammography, especially in cases involving dense breast tissue. The integration of artificial intelligence (AI) and machine learning algorithms has further augmented the diagnostic accuracy by assisting radiologists in the interpretation of mammographic images, reducing false positives and enhancing efficiency.

Key Market Drivers

Increasing Prevalence of Breast Cancer

The increasing prevalence of breast cancer has become a driving force behind the growth of the global digital mammography market. Breast cancer remains one of the most common cancers globally, affecting millions of women each year. As awareness campaigns and early detection initiatives gain momentum, the demand for advanced diagnostic technologies such as digital mammography is on the rise. Digital mammography offers several advantages over traditional film-based mammography, including improved image quality, faster image acquisition, and the ability to manipulate and store digital images efficiently. These advantages are crucial in the early detection of breast cancer, enabling healthcare professionals to identify abnormalities with greater precision. Breast cancer is 1.7 times more prevalent in women over 65 compared to those aged 45-64 and 10 times more common than in women under 45. According to an NCBI research article, breast cancer incidence increases with age, ranging from 1.5 cases per 100,000 in women aged 20-24 to 421.3 cases per 100,000 in women aged 75-79. Notably, 95% of new cases occur in women aged 40 and older. The relative survival rates for breast cancer decline with age. Consequently, the growing geriatric population is anticipated to drive market growth during the forecast period.

Key Market Challenges

High Initial Costs and Economic Constraints

The Global Digital Mammography Market, while experiencing significant growth, grapples with a formidable challenge - the high initial costs and economic constraints associated with adopting advanced digital mammography technologies. The deployment of state-of-the-art digital mammography systems requires a substantial upfront investment, posing a barrier to accessibility, particularly in resource-constrained healthcare settings.

The technology involves cutting-edge imaging systems, often accompanied by advanced software for image processing and analysis. While these innovations contribute to superior diagnostic accuracy and improved patient outcomes, they come at a considerable price. Healthcare institutions, especially those in developing regions, often face budgetary constraints that make it challenging to allocate funds for such high-cost investments.

Key Market Trends

Rise of 3D Mammography (Digital Breast Tomosynthesis)

The rise of 3D mammography, also known as digital breast tomosynthesis (DBT), has emerged as a transformative force propelling the global digital mammography market to new heights. Digital breast tomosynthesis represents a significant advancement over traditional 2D mammography by providing a three-dimensional view of the breast tissue. This revolutionary technology allows radiologists to examine the breast in multiple thin slices, offering a more detailed and comprehensive assessment of abnormalities. As breast cancer detection and diagnosis become increasingly sophisticated, the demand for 3D mammography has surged, driven by its ability to improve the accuracy of breast cancer screenings.

One of the key factors contributing to the growth of the global digital mammography market is the enhanced diagnostic capabilities offered by 3D mammography. This technology reduces the limitations associated with overlapping breast tissue in traditional 2D mammography, leading to a reduction in false positives and false negatives. The improved accuracy translates to better-informed clinical decisions, ensuring that potential abnormalities are identified more precisely. As a result, 3D mammography is becoming the standard of care in breast cancer screening, further driving its adoption and contributing to the overall expansion of the digital mammography market.

Key Market Players

• Hologic Inc
• GE Healthcare
• Koninklijke Philips NV
• Siemens Healthcare GmBH
• Fujifilm Corporation
• Planmed Oy
• Toshiba Medical Systems
• Metaltronica S.p.A

Report Scope:

In this report, the Global Digital Mammography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Mammography Market, By Product:

• 2D Full Field Digital Mammography Tomosynthesis
• 3D Full Field Digital Mammography Tomosynthesis

Digital Mammography Market, By End-User:

• Hospitals
• Ambulatory Surgical Centers
• Other End-Users

Digital Mammography Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Mammography Market.

Available Customizations:

Global Digital Mammography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Digital Mammography Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product (2D Full Field Digital Mammography Tomosynthesis, 3D Full Field Digital Mammography Tomosynthesis)
  • 4.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Other End-Users)
  • 4.2.3. By Region
  • 4.2.4. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Product
  • 4.3.2. By End-User
  • 4.3.3. By Region

5. Asia Pacific Digital Mammography Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
  • 5.2.2. By End-User
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Digital Mammography Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product
      • 5.3.1.2.2. By End-User
  • 5.3.2. India Digital Mammography Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product
      • 5.3.2.2.2. By End-User
  • 5.3.3. Australia Digital Mammography Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product
      • 5.3.3.2.2. By End-User
  • 5.3.4. Japan Digital Mammography Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product
      • 5.3.4.2.2. By End-User
  • 5.3.5. South Korea Digital Mammography Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product
      • 5.3.5.2.2. By End-User

6. Europe Digital Mammography Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End-User
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Digital Mammography Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End-User
  • 6.3.2. Germany Digital Mammography Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End-User
  • 6.3.3. Spain Digital Mammography Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End-User
  • 6.3.4. Italy Digital Mammography Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By End-User
  • 6.3.5. United Kingdom Digital Mammography Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By End-User

7. North America Digital Mammography Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End-User
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Digital Mammography Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End-User
  • 7.3.2. Mexico Digital Mammography Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End-User
  • 7.3.3. Canada Digital Mammography Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End-User

8. South America Digital Mammography Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End-User
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Digital Mammography Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End-User
  • 8.3.2. Argentina Digital Mammography Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End-User
  • 8.3.3. Colombia Digital Mammography Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End-User

9. Middle East and Africa Digital Mammography Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End-User
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Digital Mammography Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End-User
  • 9.3.2. Saudi Arabia Digital Mammography Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End-User
  • 9.3.3. UAE Digital Mammography Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End-User
  • 9.3.4. Egypt Digital Mammography Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Product
      • 9.3.4.2.2. By End-User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Digital Mammography Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Hologic Inc .
  • 14.1.1. Company Snapshot
  • 14.1.2. Products & Services
  • 14.1.3. Current Capacity Analysis
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. GE Healthcare
• 14.3. Koninklijke Philips NV
• 14.4. Siemens Healthcare GmBH
• 14.5. Fujifilm Corporation
• 14.6. Planmed Oy
• 14.7. Toshiba Medical Systems
• 14.8. Metaltronica S.p.A

15. Strategic Recommendations

16. About Us & Disclaimer